COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 184 filers reported holding COHERUS BIOSCIENCES INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,496,000 | -12.4% | 400,000 | 0.0% | 0.21% | -15.9% |
| Q2 2023 | $1,708,000 | +24.9% | 400,000 | +100.0% | 0.25% | +23.0% |
| Q1 2023 | $1,368,000 | +49.0% | 200,000 | +72.6% | 0.20% | +53.4% |
| Q4 2022 | $917,928 | -87.3% | 115,900 | -84.5% | 0.13% | -85.0% |
| Q3 2022 | $7,208,000 | +32.7% | 750,000 | 0.0% | 0.88% | +7.3% |
| Q2 2022 | $5,430,000 | -43.9% | 750,000 | 0.0% | 0.82% | -57.5% |
| Q1 2022 | $9,683,000 | -6.7% | 750,000 | +15.4% | 1.94% | -7.1% |
| Q4 2021 | $10,374,000 | -0.7% | 650,000 | 0.0% | 2.09% | -3.8% |
| Q3 2021 | $10,446,000 | +16.2% | 650,000 | 0.0% | 2.17% | +21.2% |
| Q2 2021 | $8,990,000 | -5.3% | 650,000 | 0.0% | 1.79% | -33.0% |
| Q1 2021 | $9,497,000 | -15.9% | 650,000 | 0.0% | 2.67% | +54.9% |
| Q4 2020 | $11,297,000 | +12.0% | 650,000 | +18.2% | 1.72% | -5.5% |
| Q3 2020 | $10,087,000 | +2.7% | 550,000 | 0.0% | 1.82% | +91.1% |
| Q2 2020 | $9,823,000 | +73.0% | 550,000 | +57.1% | 0.96% | +19.8% |
| Q1 2020 | $5,677,000 | – | 350,000 | – | 0.80% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |